Cresilon is a series c plus startup based in United States.
Cresilon is a startup founded in 2013 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Cresilon develops advanced hemostatic materials to stop bleeding rapidly. Their technology is based on a proprietary hydrogel that can be applied to wounds of varying severity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.